Bergeron C - Search Results

1

Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.

Quereux C, Pornel B, Bergeron C, Ferenczy A. Quereux C, et al. Among authors: bergeron c. Maturitas. 2006 Feb 20;53(3):299-305. doi: 10.1016/j.maturitas.2005.05.015. Epub 2005 Jul 25. Maturitas. 2006. PMID: 16043317

2

Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone.

Bergeron C, Ferenczy A. Bergeron C, et al. Maturitas. 2001 Jan 31;37(3):191-9. doi: 10.1016/s0378-5122(00)00176-6. Maturitas. 2001. PMID: 11173181 Clinical Trial.

3

Endometrial response to estrogen-androgen stimulation.

Gelfand MM, Ferenczy A, Bergeron C. Gelfand MM, et al. Among authors: bergeron c. Prog Clin Biol Res. 1989;320:29-40. Prog Clin Biol Res. 1989. PMID: 2690140 Review. No abstract available.

4

Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate.

Bergeron C, Nogales FF, Rechberger T, Tatarchjuk T, Zipfel L. Bergeron C, et al. Maturitas. 2010 Jun;66(2):201-5. doi: 10.1016/j.maturitas.2010.03.007. Epub 2010 Apr 7. Maturitas. 2010. PMID: 20378287 Clinical Trial.

5

Endometrial safety assessment of a specific and standardized soy extract according to international guidelines.

Palacios S, Pornel B, Bergeron C, Chantre P, Nogales F, Aubert L, Vazquez F, Eden J, Mares P. Palacios S, et al. Among authors: bergeron c. Menopause. 2007 Nov-Dec;14(6):1006-11. doi: 10.1097/gme.0b013e3180590c42. Menopause. 2007. PMID: 17603393 Clinical Trial.

6

Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year.

Gompel A, Bergeron C, Jondet M, Dhont M, Van der Mooren MJ, Toth KS, Panay N, Von Holst T. Gompel A, et al. Among authors: bergeron c. Maturitas. 2000 Oct 31;36(3):209-15. doi: 10.1016/s0378-5122(00)00144-4. Maturitas. 2000. PMID: 11063903 Clinical Trial.

7

Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues.

Bergeron C, Ferenczy A, Shyamala G. Bergeron C, et al. Lab Invest. 1988 Mar;58(3):338-45. Lab Invest. 1988. PMID: 3347010

8

Pathology and physiopathology of adenomyosis.

Bergeron C, Amant F, Ferenczy A. Bergeron C, et al. Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):511-21. doi: 10.1016/j.bpobgyn.2006.01.016. Epub 2006 Mar 24. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16563870 Review.

9

Histology of the human endometrium: from birth to senescence.

Ferenczy A, Bergeron C. Ferenczy A, et al. Among authors: bergeron c. Ann N Y Acad Sci. 1991;622:6-27. doi: 10.1111/j.1749-6632.1991.tb37847.x. Ann N Y Acad Sci. 1991. PMID: 2064209 Review.

10

Oncocytic metaplasia in endometrial hyperplasia and carcinoma.

Bergeron C, Ferenczy A. Bergeron C, et al. Int J Gynecol Pathol. 1988;7(1):93-5. doi: 10.1097/00004347-198803000-00010. Int J Gynecol Pathol. 1988. PMID: 3350620 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page